Skip to main content

Qsymia News

FDA Approves Qsymia for Chronic Weight Management in Certain Pediatric Patients Aged 12 years and Older

June 27, 2022 – The U.S. Food and Drug Administration has approved a supplemental indication for Qsymia (phentermine and topiramate extended-release capsules) for chronic weight management in...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Weight Loss (Obesity / Overweight)

Qsymia patient information at Drugs.com